| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
disease | 0.800 | strong | 0.973 | 70 | 1 | 2010 | 2020 | ||||||||
|
G protein subunit alpha q | 0.516 | 0.808 | 0.98 |
|
disease | 0.800 | None | 0.984 | 56 | 2 | 2008 | 2019 | ||||||||
|
G protein subunit alpha 11 | 0.563 | 0.731 | 0.89 |
|
disease | 0.800 | None | 0.977 | 39 | 1 | 2010 | 2019 | ||||||||
|
splicing factor 3b subunit 1 | 0.511 | 0.731 | 1.00 |
|
disease | 0.600 | None | 0.929 | 13 | 0 | 2013 | 2019 | ||||||||
|
cysteinyl leukotriene receptor 2 | 0.633 | 0.538 | 1.0E-04 |
|
disease | 0.530 | None | 1.000 | 3 | 0 | 2016 | 2019 | ||||||||
|
phospholipase C beta 4 | 0.610 | 0.731 | 3.0E-06 |
|
disease | 0.430 | None | 1.000 | 3 | 0 | 2016 | 2019 | ||||||||
|
eukaryotic translation initiation factor 1A X-linked | 0.716 | 0.231 | 0.91 |
|
disease | 0.370 | None | 1.000 | 7 | 0 | 2013 | 2017 | ||||||||
|
jumonji domain containing 6, arginine demethylase and lysine hydroxylase | 0.615 | 0.654 | 0.93 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2018 | 2019 | ||||||||
|
tyrosyl-DNA phosphodiesterase 1 | 0.612 | 0.538 | 1.3E-17 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
CLPTM1 like | 0.551 | 0.654 | 4.4E-05 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2017 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0.920 | 25 | 3 | 2003 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1996 | 2018 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 2000 | 2018 | ||||||||
|
mitogen-activated protein kinase kinase 7 | 0.419 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2012 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 1996 | 2019 | ||||||||
|
oncomodulin | 0.751 | 0.423 | 1.1E-08 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2006 | 2018 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2012 | 2019 | ||||||||
|
Ras association domain family member 1 | 0.420 | 0.808 | 4.9E-06 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2007 | 2018 | ||||||||
|
Yes associated protein 1 | 0.432 | 0.808 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2014 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2006 | 2020 | ||||||||
|
preferentially expressed antigen in melanoma | 0.531 | 0.577 | 2.4E-07 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2016 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2012 | 2019 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2019 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
disease | 0.050 | None | 0.600 | 5 | 0 | 2008 | 2018 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2008 | 2019 |